W. Bennett Love

Mr. Love has held financial, strategic and general senior management positions and invested in biotech companies for over twenty years. In addition to his role with BioKier, he is a co-founder and Vice President of Synereca Pharmaceuticals, a startup focused on the antibacterial field.

Prior to cofounding Synereca, his biotech roles included the development, funding, and collaborations of Ercole Biotech and its subsequent sale to AVI BioPharma; the management buyout of Medic Computer Systems; the $75 million IPO for Sphinx Pharmaceuticals; the $37 million IPO for what became Incara Pharmaceuticals; and the initial technology university spinout funding of Renaissance Cell Technologies. He received his MBA and undergraduate degrees from the University of North Carolina.